Poor Research

Research articles
News and updates
Information (forthcoming)
Podcast
Community voices (forthcoming)
Events

For Physicians | Government reports & letters | Lyme Controversy | Miscellaneous | Poor Research | Voices on Lyme
Patient Lyme disease websites prioritize science; public health websites prioritize consistent messaging—Comment on ‘Lyme disease prevention: A content analysis of Canadian patient group and government websites’
ByCanLyme Team March 31, 2021March 31, 2021
Dear Editor, A recent article ‘Lyme disease prevention: A content analysis of Canadian patient group and government websites’ by Journault et al. (2020) in Zoonoses and Public Health describes content analysis of three public health and three patient group Lyme disease websites with respect to information on prevention of infection. The (relatively few) divergent items…
Read More Patient Lyme disease websites prioritize science; public health websites prioritize consistent messaging—Comment on ‘Lyme disease prevention: A content analysis of Canadian patient group and government websites’
For Physicians | Government | International News | Lyme Controversy | Lyme in Alberta | Lyme in BC | Lyme in Manitoba | Lyme in New Brunswick | Lyme in Newfoundland | Lyme in Nova Scotia | Lyme in Ontario | Lyme in P.E.I. | Lyme in quebec | Lyme in Saskatchewan | Miscellaneous | Poor Research | Voices on Lyme
Canada implicated once again in covert non-transparent manipulation of World Health Organization
ByCanLyme Team June 24, 2020July 27, 2020
When will the corruption stop? CanLyme is a member of the Ad Hoc Committee for Health Equity. “A request to have ‘Congenital Lyme borreliosis’ listed as a ‘stand-alone’ category in the new ICD-11 codes was made by the Ad Hoc Committee for Health Equity in ICD-11 Borreliosis Codes, submitted March 27, 2017 by Jenna Luché-Thayer…
Read More Canada implicated once again in covert non-transparent manipulation of World Health Organization
Co-infections | For Physicians | Lyme Controversy | News from CanLyme | Poor Research | Voices on Lyme
1990 archive, MacLean’s magazine: A growing menace
ByCanLyme Team October 22, 2019July 27, 2020
[CanLyme Note: Here we are 30 years later since the formation of the Lyme Borreliosis Society of BC, later rolled into CanLyme, and our government funded agencies with their bureaucrats collude with private medical associations (IDSA, AMMI, CPS), pharma, and medical insurers to deny access to appropriate diagnosis and care to hundreds of thousands. Our…
Read More 1990 archive, MacLean’s magazine: A growing menace
For Physicians | International News | Lyme Controversy | Lyme in Alberta | Lyme in BC | Lyme in Manitoba | Lyme in New Brunswick | Lyme in Newfoundland | Lyme in Nova Scotia | Lyme in Ontario | Lyme in quebec | Lyme in Saskatchewan | Media | Miscellaneous | News from CanLyme | Poor Research | Voices on Lyme
Global TV News: Why Lyme disease is on the rise, explained
ByCanLyme Team August 8, 2019July 27, 2020
[CanLyme Note: Both AIDS and Lyme disease arose as an issue in the late 1970’s with the first case of Lyme reported in Quebec in 1977. As pointed out in this piece, since then there have been over 11,000 clinical trials for AIDS yet only 60 for Lyme disease. Lyme disease research funding in Canada…
Read More Global TV News: Why Lyme disease is on the rise, explained
For Physicians | Guidelines - Boxing-in disease | International News | Lyme Controversy | Medical Publications | Miscellaneous | Poor Research
The new draft of the Infectious Disease Society of America (IDSA) guidelines open for public comment for 45 days.
ByCanLyme Team June 27, 2019July 27, 2020
The IDSA has presented their draft guidelines which with a brief scan appear not much different then their old controversial poorly evidenced guidelines. Much of the same old players and 3 token patients. Typical unequal representation. Public comments close August 10th. Take your time, make notes before you enter their controlled comment format process as…
Read More The new draft of the Infectious Disease Society of America (IDSA) guidelines open for public comment for 45 days.
Co-infections | For Physicians | International News | Lyme Controversy | Miscellaneous | Poor Research | Research
The Scientist – Opinion: The “Money Culture” in Academic Biomedical Research
ByCanLyme Team April 15, 2019July 27, 2020
[CanLyme Note: This for profit money drive takes medical research away from cure to ‘a drug for every symptom’. In Canada, relative to Lyme disease, the private Association of Medical Microbiology and Infectious Disease of Canada (AMMI), is an extension of the ‘do not cure’ medical money machine. They offer opinion and poorly designed research to…
Read More The Scientist – Opinion: The “Money Culture” in Academic Biomedical Research
For Physicians | Lyme Controversy | Lyme in Alberta | Lyme in BC | Lyme in Manitoba | Lyme in New Brunswick | Lyme in Newfoundland | Lyme in Nova Scotia | Lyme in Ontario | Lyme in P.E.I. | Lyme in quebec | Lyme in Saskatchewan | Miscellaneous | News from CanLyme | Poor Research | Research | Voices on Lyme
Lyme advocates say Canada offers “toxic tokenism” to patients
ByCanLyme Team January 27, 2019July 27, 2020
The Canadian government recently announced new investment in Lyme disease research. However, Canadian Lyme advocates fear that the patient voice will be excluded from the decision-making process. In the following article, the Canadian Lyme Consortium (CLC)–made up of advocates, patients, researchers and practitioners–offers background and context. By Vett Lloyd, PhD; Liz Zubek, MD, CCFP FCFP; Sue Faber and Jennifer Kravis,…
Read More Lyme advocates say Canada offers “toxic tokenism” to patients
Co-infections | For Physicians | International News | Lyme Controversy | Miscellaneous | Poor Research | Research | Voices on Lyme
Interview: The flawed science behind the current global Lyme policies, diagnostics and treatment
ByCanLyme Team December 5, 2017July 27, 2020
Posted on on-lyme.org Dec 2nd, 2017 Written by Huib Holly Ahern is a professor of microbiology as well as the mother of a child that was severely affected by Lyme Disease. Because of this personal experience and her professional background and training, she was able to dissect the flaws in scientific reasoning that underlie decades of…
Read More Interview: The flawed science behind the current global Lyme policies, diagnostics and treatment
For Physicians | Lyme in Manitoba | Medical Publications | Miscellaneous | Poor Research | Research
Human seroprevalence of Borrelia miyamotoi in Manitoba, Canada, in 2011–2014: a cross-sectional study
ByCanLyme Team September 21, 2017July 27, 2020
[CanLyme Note: This is a very interesting and important study and we are pleased that this is being looked at but there are some glaring omissions in the document. Not made clear in the results is that a significant percentage of obviously symptomatic patients (why their blood was tested in the first place) would be completely…
Read More Human seroprevalence of Borrelia miyamotoi in Manitoba, Canada, in 2011–2014: a cross-sectional study
Co-infections | For Physicians | International News | Lyme Controversy | Medical Publications | Miscellaneous | Poor Research | Research | Voices on Lyme
Anti-science old guard taking last dying breaths of continuing to misinform physicians using tax payer dollars
ByCanLyme Team February 23, 2017July 27, 2020
Here is their opinion article title, amazing in 2017 how poorly they reference their evidence… “False and Misleading Information about Lyme Disease” Here is one of their uniformed statements, “Persistent, unexplained subjective symptoms such as chronic fatigue and pain are common in the general population. Annual surveys by the Centers for Disease Control and…
Read More Anti-science old guard taking last dying breaths of continuing to misinform physicians using tax payer dollars
For Physicians | Lyme Controversy | Miscellaneous | Poor Research | Research | Voices on Lyme
Flunk the Lyme test? Just wait and get sicker
ByCanLyme Team January 31, 2017July 27, 2020
January, 2017, Huffington Post Sin Lee, a pathologist and scientist, believes the deck is stacked in the quest to air new ideas on Lyme disease. Too many science journals telling him to take his research elsewhere. Too many deftly worded rejections. Too little inclination to engage in a fair fight over the facts and fiction…
Read More Flunk the Lyme test? Just wait and get sicker
For Physicians | Lyme Controversy | Medical Publications | Miscellaneous | Poor Research | Research | Voices on Lyme
CanLyme director responds to Canadian Medical Association Journal article
ByTeam August 31, 2016April 21, 2023
Response to Doctors Gregson and Quach Robert G. Murray, DDS, Director, CanLyme Re: “The Lyme law” Zubek, 187:520-521doi:10.1503/cmaj.115-0029 The problem with Lyme disease in Canada will only continue to grow to the point where the numbers affected will simply overwhelm the idea that Lyme Borreliosis (LB) is hard to catch and easy to treat with…
Read More CanLyme director responds to Canadian Medical Association Journal article
For Physicians | International News | Lyme Controversy | Medical Publications | Miscellaneous | Poor Research | Research | Voices on Lyme
Doctor comments on Lyme disease treatment
ByTeam June 15, 2016April 21, 2023
[CanLyme note: It is very common for mainstream physicians who subscribe to the Infectious Disease Society of America guidelines to design studies in such a fashion that the outcome is pre-determined. These studies have no value, nor scientific merit. The divide is created intentionally.] Infectious Disease doctor, Sam Donta, responds to article, To the Editor:…
Read More Doctor comments on Lyme disease treatment
For Physicians | Lyme Controversy | Medical Publications | Miscellaneous | News from CanLyme | Poor Research | Support in your area or country | Voices on Lyme
A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library
ByTeam May 25, 2016April 21, 2023
Frontiers in Microbiology, May 23, 2016 Although currently recommended antibiotics for Lyme disease such as doxycycline or amoxicillin cure the majority of the patients, about 10–20% of patients treated for Lyme disease may experience lingering symptoms including fatigue, pain, or joint and muscle aches. Under experimental stress conditions such as starvation or antibiotic exposure, Borrelia…
Read More A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library
Conferences | For Physicians | Lyme Controversy | Lyme in Alberta | Lyme in BC | Lyme in Manitoba | Lyme in New Brunswick | Lyme in Newfoundland | Lyme in Nova Scotia | Lyme in Ontario | Lyme in quebec | Lyme in Saskatchewan | Medical Publications | Miscellaneous | Poor Research | Research | Voices on Lyme
Watch CTV news interview of Dr. Todd Hatchette. A very good example of how opinion, not science, is driving Lyme borreliosis policy in Canada… in spite of evidence presented by experts in Ottawa, May 15th to 17th, 2016.
ByTeam May 24, 2016April 21, 2023
[Lyme disease is actually Lyme borreliosis. an infection caused by many different strains/genotypes of Borrelia bacteria] How can one rationalize making progress from the patient’s expert perspective when officially, by tax payer funded microbiologists, opinion is put forward as fact with no supporting science. Dr. Todd Hatchette attended the recent three day conference in Ottawa…
Read More Watch CTV news interview of Dr. Todd Hatchette. A very good example of how opinion, not science, is driving Lyme borreliosis policy in Canada… in spite of evidence presented by experts in Ottawa, May 15th to 17th, 2016.

Poor Research

Patient Lyme disease websites prioritize science; public health websites prioritize consistent messaging—Comment on ‘Lyme disease prevention: A content analysis of Canadian patient group and government websites’

Canada implicated once again in covert non-transparent manipulation of World Health Organization

1990 archive, MacLean’s magazine: A growing menace

Global TV News: Why Lyme disease is on the rise, explained

The new draft of the Infectious Disease Society of America (IDSA) guidelines open for public comment for 45 days.

The Scientist – Opinion: The “Money Culture” in Academic Biomedical Research

Lyme advocates say Canada offers “toxic tokenism” to patients

Interview: The flawed science behind the current global Lyme policies, diagnostics and treatment

Human seroprevalence of Borrelia miyamotoi in Manitoba, Canada, in 2011–2014: a cross-sectional study

Anti-science old guard taking last dying breaths of continuing to misinform physicians using tax payer dollars

Flunk the Lyme test? Just wait and get sicker

CanLyme director responds to Canadian Medical Association Journal article

Doctor comments on Lyme disease treatment

A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library

Watch CTV news interview of Dr. Todd Hatchette. A very good example of how opinion, not science, is driving Lyme borreliosis policy in Canada… in spite of evidence presented by experts in Ottawa, May 15th to 17th, 2016.

Sign up

Looking at Lyme, podcast

Recent Posts